Published in Patient Relat Outcome Meas on November 06, 2015
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ (2013) 9.38
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med (2014) 5.65
Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol (2010) 5.15
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer (2005) 4.55
Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43
A review of human carcinogens--part D: radiation. Lancet Oncol (2009) 4.22
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg (2005) 3.80
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer (2007) 3.50
The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol (2006) 3.30
Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23
Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol (2003) 2.56
Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol (2004) 2.54
Smartphone applications for melanoma detection by community, patient and generalist clinician users: a review. Br J Dermatol (2015) 2.17
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial. JAMA (2014) 2.13
How much melanoma is caused by sun exposure? Melanoma Res (1993) 1.95
Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med (2009) 1.85
An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol (1998) 1.76
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol (2011) 1.75
Legislation restricting access to indoor tanning throughout the world. Arch Dermatol (2012) 1.72
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71
Health-related quality of life in patients with melanoma expressed as utilities and disability weights. Br J Dermatol (2014) 1.42
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol (2005) 1.38
Promoting sun safety among US Postal Service letter carriers: impact of a 2-year intervention. Am J Public Health (2007) 1.33
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst (2010) 1.31
Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database. Appl Health Econ Health Policy (2009) 1.27
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges (2013) 1.25
Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children. Pediatrics (2008) 1.23
Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol (2008) 1.22
Estimating the residency expansion required to avoid projected primary care physician shortages by 2035. Ann Fam Med (2015) 1.21
Compliance with restrictions on sale of indoor tanning sessions to youth in Minnesota and Massachusetts. J Am Acad Dermatol (2006) 1.20
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer (2010) 1.19
Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst (2011) 1.17
Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J (2009) 1.16
Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16
Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol (2010) 1.16
Diagnostic inaccuracy of smartphone applications for melanoma detection: representative lesion sets and the role for adjunctive technologies. JAMA Dermatol (2013) 1.14
General and plastic surgery devices: reclassification of ultraviolet lamps for tanning, henceforth to be known as sunlamp products and ultraviolet lamps intended for use in sunlamp products. Final order. Fed Regist (2014) 1.10
Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol (2001) 1.05
Cost effectiveness of adjuvant interferon in node-positive melanoma. J Clin Oncol (2007) 1.05
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res (2007) 1.04
Cost of skin cancer in England. Eur J Health Econ (2008) 1.03
Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data. Arch Dermatol (2010) 1.02
Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol (2010) 0.99
Effectiveness of a skin cancer control educational intervention for internal medicine housestaff and attending physicians. J Gen Intern Med (1997) 0.98
Melanoma and other skin lesion detection using smart handheld devices. Methods Mol Biol (2015) 0.97
Role of primary care in the prevention of malignant melanoma. Br J Gen Pract (1994) 0.96
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology (2005) 0.95
Healthcare providers' sun-protection promotion and at-risk clients' skin-cancer-prevention outcomes. Prev Med (2004) 0.95
Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review. BMC Res Notes (2014) 0.95
Gaining momentum: New options and opportunities for the treatment of advanced melanoma. Cancer Treat Rev (2015) 0.93
Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol (2009) 0.93
Follow-up schedules after treatment for malignant melanoma. Br J Surg (2008) 0.92
Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev (2015) 0.92
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol (2014) 0.91
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly (2011) 0.90
Introducing the third US Preventive Services Task Force. Am J Prev Med (2001) 0.90
Strategies to reduce indoor tanning: current research gaps and future opportunities for prevention. Am J Prev Med (2013) 0.89
The conundrum of follow-up: should it be abandoned? Surg Oncol Clin N Am (2006) 0.89
Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. Br J Dermatol (2014) 0.88
Epidemiology, risk factors, prevention, and early detection of melanoma. Surg Clin North Am (2014) 0.88
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res (2010) 0.86
Physician sun protection counseling: prevalence, correlates, and association with sun protection practices among US adolescents and their parents, 2004. Prev Med (2010) 0.85
An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil. An Bras Dermatol (2009) 0.85
Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res (2012) 0.84
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial). J Immunother (2011) 0.84
Sunscreens: a review of health benefits, regulations, and controversies. Dermatol Clin (2014) 0.84
Skin cancer: follow-up, rehabilitation, palliative and supportive care. J Dtsch Dermatol Ges (2008) 0.83
Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg (2014) 0.83
Review of diagnostic imaging modalities for the surveillance of melanoma patients. Dermatol Res Pract (2011) 0.82
Follow-up recommendations for patients with stage I malignant melanoma. J Dermatol Surg Oncol (1994) 0.82
The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma. Br J Surg (1985) 0.81
Sun protection counseling by pediatricians. Ambul Pediatr (2002) 0.80
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res (2013) 0.80
Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. Eur J Cancer (1992) 0.80
The Sydney Melanoma Unit--a multidisciplinary melanoma treatment center. Surg Clin North Am (2003) 0.79
The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs. Melanoma Res (2013) 0.78
Melanoma: treatment guidelines for patients (part 2). Dermatol Nurs (2005) 0.77
Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels. Eur J Surg Oncol (1997) 0.77
Staging work-up and post-treatment surveillance of patients with melanoma. Clin Plast Surg (2000) 0.77
Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic. JAMA Dermatol (2015) 0.77
Awareness, Attitude, and Adherence to Preventive Measures in Patients at High Risk of Melanoma. A Cross-Sectional Study on 185 Patients. J Cancer Educ (2015) 0.76
Sunscreen and melanoma: what is the evidence? J Clin Oncol (2010) 0.76
Quality of life in localised malignant melanoma. Ann Oncol (2010) 0.76
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol (2016) 0.75
Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol (2017) 0.75
Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol (2017) 0.75